Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04943627
Title Balstilimab in Patients With Recurrent Cervical Cancer.
Recruitment Terminated
Gender female
Phase Phase III
Variant Requirements No
Sponsors Agenus Inc.
Indications

cervical squamous cell carcinoma

cervical adenosquamous carcinoma

cervical adenocarcinoma

Therapies

Topotecan

Balstilimab

Gemcitabine

Irinotecan

Pemetrexed Disodium

Vinorelbine

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Optimum Research (Southwest Women's Oncology Center) Albuquerque New Mexico 87109 United States Details
Hematology Center after prof. R. Yeolyan Yerevan 0014 Armenia Details
National Center of Oncology named after V.A. Fanarjian Yerevan 0052 Armenia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field